Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genotype-dependent biochemical response to elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis: A 24-month real-world study.

Respiratory medicine·2026

Same author

Brown adipose-derived mesenchymal stromal cells improve sepsis-induced multiorgan dysfunction more than white adipose cells in obese rats.

Cytotherapy·2026

Same author

Phage therapy in people with cystic fibrosis: A systematic review.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Same author

Extracellular vesicles from mesenchymal stromal cells as a promising therapy for ARDS: a systematic review of preclinical studies.

Frontiers in medicine·2025

Same author

Extracellular Vesicles: Multimodal Tools for Diagnosis, Prognosis, and Therapy in Respiratory Diseases.

Expert reviews in molecular medicine·2025

Same author

Building Lay Society Knowledge and Education for Health Technology Assessment and Policy Engagement: Case of CFTR Modulator Access in Brazil.

Healthcare (Basel, Switzerland)·2025

Same journal

RETRACTION: The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells.

Stem cells international·2026

Same journal

RETRACTION: Uric Acid-Induced Adipocyte Dysfunction Is Attenuated by HO-1 Upregulation: Potential Role of Antioxidant Therapy to Target Obesity.

Stem cells international·2026

Same journal

In Vitro Evaluation of Mechanical Fat Processing Devices: Impact on Adipocytes and Adipose-Derived Stem Cells.

Stem cells international·2026

Same journal

Hyaluronic Acid Hydrogel Inhibits Autophagy Through the miR-181a-5p/ATG5 Molecular Axis to Promote the Adipogenic Differentiation of Adipose-Derived Stem Cells.

Stem cells international·2026

Same journal

RETRACTION: Naringin Stimulates Osteogenic Differentiation of Rat Bone Marrow Stromal Cells via Activation of the Notch Signaling Pathway.

Stem cells international·2026

Same journal

Efficient Derivation and Transcriptional Characterization of Mouse Extra-Embryonic Endoderm Stem Cell Lines Generated by Somatic Cell Nuclear Transfer.

Stem cells international·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 22, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

Cell-Based Therapy for Silicosis.

Miquéias Lopes-Pacheco¹, Elga Bandeira¹, Marcelo M Morales¹

¹Laboratory of Cellular and Molecular Physiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Stem Cells International

|April 12, 2016

Summary

This summary is machine-generated.

Silicosis, a common lung disease, currently lacks effective treatments. This review explores silica

More Related Videos

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

Related Experiment Videos

Last Updated: Mar 22, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

Area of Science:

Pulmonary Medicine
Toxicology
Regenerative Medicine

Background:

Silicosis is the most prevalent global pneumoconiosis, disproportionately affecting developing nations.
Current treatments for silica-induced lung injury are ineffective in halting or reversing disease progression.
There is a critical need for novel therapeutic strategies to mitigate silicosis morbidity and mortality.

Purpose of the Study:

To elucidate the primary mechanisms of lung damage induced by silica particle exposure.
To review and assess the potential of cell-based therapies as a treatment for silicosis.

Main Methods:

Literature review focusing on the pathophysiology of silicosis.
Analysis of research data on cell-based therapeutic approaches for lung injury.

Main Results:

Silica particles trigger complex inflammatory and fibrotic pathways in the lungs.
Preclinical studies suggest cell-based therapies show promise in ameliorating silica-induced lung damage.

Conclusions:

Understanding silica's mechanisms of lung injury is crucial for developing effective treatments.
Cell-based therapy represents a promising avenue for future silicosis treatment strategies.